NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MiRus

MiRus

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://www.mirusmed.com/

Last Round

Corporate Funding

May 15, 2026

Est. Valuation

$4.44B

Total Funding Raised

$1.57B

Company Overview

MiRus is a medical technology company that develops and commercializes proprietary biomaterials, implants, and procedural solutions for the treatment of spinal, orthopedic, and cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical devicestranscatheter aortic valve replacementTAVRspine implantsbiocompatible materialssurgical implantsmedtechMoRe alloysurgical planningstructural heartorthopedic hardwareclinical decision supportsurgical navigation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiRus Comparables

Compare MiRus with similar companies based on industry and business-model similarity.

MiRus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Meril Life Sciences
83%
Anteris Technologies Global Corp
83%
Edwards Lifesciences
81%

MiRus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 15, 2026
Series DJul 27, 2021

Key People

Founding team and executive leadership

Jay Yadav

Founder And CEO

Founding Team

David Toney

Chief Financial Officer

Executive Team

Noah M. Roth

COO At MiRus, LLC

Executive Team

MiRus Investors

Notable investors and investment history

MiRus investors
InvestorRounds
Mammoth ScientificSeries C, Series B, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    Pivotal trial for TAVR system underway, targeting FDA/EMA submissions.

  • Jul 27, 2021

    $65M round led by Mammoth Scientific.

MiRus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MiRus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MiRus's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range136
Year Founded2016
Last FundingMay 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.